Research Paper On Dry Eye Disease
FDA approves new medication for dry eye disease
In the U.S roughly 16 million people are diagnosed with dry eye disease. (3)“Dry eye disease includes a group of conditions in which the eye does not produce an adequate volume of tears or when the tears are not of the correct consistency.‘ Dry eyes disease affects roughly five percent of the adult population age 30-40 and ten to fifteen percent of adults over the age of 65 [1]. If the disease is left untreated it can cause serious issues such as inflammation to the eye, ulcers or scares in the cornea, as well as serious pain. [2]
Shire, a biotechnology company finally got the approval for Xiidra (lifitegrast ophthalmic solution) from the U.S. Food and Drug Administration (FDA), after resubmitting
In the U.S roughly 16 million people are diagnosed with dry eye disease. (3)“Dry eye disease includes a group of conditions in which the eye does not produce an adequate volume of tears or when the tears are not of the correct consistency.‘ Dry eyes disease affects roughly five percent of the adult population age 30-40 and ten to fifteen percent of adults over the age of 65 [1]. If the disease is left untreated it can cause serious issues such as inflammation to the eye, ulcers or scares in the cornea, as well as serious pain. [2]
Shire, a biotechnology company finally got the approval for Xiidra (lifitegrast ophthalmic solution) from the U.S. Food and Drug Administration (FDA), after resubmitting